Dental Care Clinics in Pinckney, MI Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Pinckney Implants & Periodontics Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 1245 E. Main Street, Pinckney, MI 48169 Phone: 734-531-7557 Fax: 734-531-7558 |
Michael J. Brunner, Dds, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 315 S Howell St, Pinckney, MI 48169 Phone: 734-878-3167 Fax: 734-878-3168 |
Donald A. Restauri Jr Dds Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 5589 E Mi 36, Suite 11, Pinckney, MI 48169 Phone: 810-231-2424 Fax: 810-231-2807 |
Pinckney Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1243 East Main Street, Pinckney, MI 48169 Phone: 734-878-3145 Fax: 734-878-0948 |
News Archive
New risk factor for heart disease suggests more should be on statins
Canadian scientists have discovered a new risk factor for cardiovascular disease and the significance of their discovery was so conclusive that the clinical trial was stopped before its scheduled completion date.New risk factor for heart disease suggests more should be on statins
BIDMC podiatric surgeon shares simple tips for keeping the feet healthy
It's no surprise that healthy feet are important for feeling good and staying active. With 26 bones, 33 joints and more than 100 muscles, tendons and ligaments, the foot is one of the most complex parts of the skeletal system.
Congressional mood, 'super committee' news highlight difficulties
The New York Times reports that expectations for the deficit-reduction panel continue to drop, as the Democrats' and Republicans' respective positions on trimming entitlements and raising taxes appear to be hardening. And, in the background, The Wall Street Journal notes that another government shutdown looms as lawmakers fail to make progress in striking a deal to fund the federal branch through Nov. 18.
Hyperion's HPN-100 granted FDA Fast Track Designation for urea cycle disorders
Hyperion Therapeutics, Inc. announced today that its investigational compound glycerol phenylbutyrate (HPN-100) has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) as adjunctive therapy for the chronic management of urea cycle disorders. Hyperion recently completed its phase III trial which was conducted under a Special Protocol Assessment (SPA) agreement with the FDA. The Company plans to announce results from that trial later this year.
AI could help better diagnose blood diseases
How can we better diagnose blood diseases? A research group led by Helmholtz Munich aims to answer this question with artificial intelligence (AI).
› Verified 7 days ago